BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 17515463)

  • 21. Receptor for activated C-kinase 1, a novel binding partner of adiponectin receptor 1.
    Xu Y; Wang N; Ling F; Li P; Gao Y
    Biochem Biophys Res Commun; 2009 Jan; 378(1):95-8. PubMed ID: 19010305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells.
    Liu Y; Ren W; Warburton R; Toksoz D; Fanburg BL
    FASEB J; 2009 Jul; 23(7):2299-306. PubMed ID: 19244313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.
    West J; Fagan K; Steudel W; Fouty B; Lane K; Harral J; Hoedt-Miller M; Tada Y; Ozimek J; Tuder R; Rodman DM
    Circ Res; 2004 Apr; 94(8):1109-14. PubMed ID: 15031260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
    Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
    Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
    Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
    Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
    Hecker M; Zaslona Z; Kwapiszewska G; Niess G; Zakrzewicz A; Hergenreider E; Wilhelm J; Marsh LM; Sedding D; Klepetko W; Lohmeyer J; Dimmeler S; Seeger W; Weissmann N; Schermuly RT; Kneidinger N; Eickelberg O; Morty RE
    Am J Respir Crit Care Med; 2010 Sep; 182(6):805-18. PubMed ID: 20522789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RACK1 associates with NHE5 in focal adhesions and positively regulates the transporter activity.
    Onishi I; Lin PJ; Diering GH; Williams WP; Numata M
    Cell Signal; 2007 Jan; 19(1):194-203. PubMed ID: 16920332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
    Wang Y; Zhang XH; Wang HL
    Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
    Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
    Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
    Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
    Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
    Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
    J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
    Jurasz P; Courtman D; Babaie S; Stewart DJ
    Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The N-terminus of the WD5 repeat of human RACK1 binds to airway epithelial NHERF1.
    Liedtke CM; Wang X
    Biochemistry; 2006 Aug; 45(34):10270-7. PubMed ID: 16922502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.